{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/23/3315876/27423/en/Galectin-Therapeutics-Announces-Positive-Type-C-Meeting-with-the-FDA-for-Belapectin-in-Patients-with-MASH-Cirrhosis-and-Portal-Hypertension.html", "message": "News view counter 811452 successfully enlarged"}